Purchase of Shares and PDMR Shareholding
Senior Independent Non-Executive Director Graham Paterson purchased 11,643 shares at 137.5p per share.
Select text to share a quote on X · sign in to keep highlights & notes in your DXRX notes
New York, Belfast and London, 31 January 2025 - Diaceutics PLC (AIM: DXRX), a leading technology and solutions provider to the pharma and biotech industry, announces that on 30 January 2025, Graham Paterson, the Senior Independent Non-Executive Director of Diaceutics PLC, purchased 11,643 ordinary shares of £0.002 in the capital of the Company ("Ordinary Shares") at a price of 137.5 pence per Ordinary Share. As a result of the purchase, Graham's shareholding is 85,141 Ordinary Shares, representing approximately 0.10% of the Company's issued share capital.
| a. | Name | Graham Paterson |
| 2 | Reason for notification | |
| a. | Position/Status | Non-Executive Director |
| b. | Initial notification/ Amendment | Initial |
| a. | Name | Diaceutics PLC |
| b. | LEI | 213800VEWQBB39ZB8J81 |
| a. | Description of the financial instrument, type of instrument Identification Code | Ordinary shares of £ 0.002 each ISIN: GB00BJQTGV64 |
| b. | Nature of the transaction | Purchase |
| c. | Price(s) and volume(s) | Share purchase: |
| Price(s) | Volume(s) | |
| 137.5 p | 11,643 | |
| f. | Place of the transaction | AIM Market of the London Stock Exchange |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.